• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PET/CT and breast cancer subtypes.

作者信息

Gilardi Laura, Colleoni Marco, Paganelli Giovanni

机构信息

Division of Nuclear Medicine, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1301-3. doi: 10.1007/s00259-013-2472-1.

DOI:10.1007/s00259-013-2472-1
PMID:23748238
Abstract
摘要

相似文献

1
PET/CT and breast cancer subtypes.正电子发射断层显像/X线计算机体层成像（PET/CT）与乳腺癌亚型
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1301-3. doi: 10.1007/s00259-013-2472-1.
2
Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.乳腺癌的分子亚型：¹⁸F-FDG PET/CT 代谢相关性。
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1304-11. doi: 10.1007/s00259-013-2418-7. Epub 2013 Apr 30.
3
Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG PET/CT）检测新辅助来曲唑治疗后早期代谢反应与激素受体阳性原发性乳腺癌患者 Ki67 标记指数降低相关：一项初步研究。
Breast Cancer. 2011 Oct;18(4):299-308. doi: 10.1007/s12282-010-0212-y. Epub 2010 Jul 9.
4
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.68Ga-HER2-Nanobody 的 I 期研究用于评估乳腺癌中 HER2 表达的 PET/CT。
J Nucl Med. 2016 Jan;57(1):27-33. doi: 10.2967/jnumed.115.162024. Epub 2015 Oct 8.
5
Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.正电子发射断层扫描/磁共振成像用于原发性乳腺癌患者的局部肿瘤分期：与正电子发射断层扫描/计算机断层扫描及磁共振成像的比较
Invest Radiol. 2015 Aug;50(8):505-13. doi: 10.1097/RLI.0000000000000197.
6
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.使用定量氟-18氟脱氧葡萄糖/正电子发射断层扫描成像参数比较三阴性乳腺癌与雌激素受体阳性/孕激素受体阳性/人表皮生长因子受体2阴性乳腺癌：一种对疾病特征描述可能有用的方法。
Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226.
7
Solitary breast cancer metastasis to the esophagus - a multimodal diagnostic approach.孤立性乳腺癌转移至食管——一种多模态诊断方法。
Z Gastroenterol. 2013 Jul;51(7):635-7. doi: 10.1055/s-0033-1335262. Epub 2013 Jul 9.
8
18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.局部晚期乳腺癌的18F-FDG半定量参数及生物学预后因素
Rev Esp Med Nucl Imagen Mol. 2012 Nov-Dec;31(6):308-14. doi: 10.1016/j.remn.2011.12.001. Epub 2012 Mar 19.
9
Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.18F-FDG PET/CT、超声检查和MRI的诊断性能。乳腺癌患者腋窝淋巴结转移的检测。
Nuklearmedizin. 2014;53(3):89-94. doi: 10.3413/Nukmed-0605-13-06. Epub 2013 Nov 13.
10
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.对于乳腺癌，肿瘤大小和增殖标志物geminin而非Ki67的表达水平与正电子发射断层扫描中18F-脱氧葡萄糖水平的最大摄取显著相关。
PLoS One. 2017 Sep 8;12(9):e0184508. doi: 10.1371/journal.pone.0184508. eCollection 2017.

引用本文的文献

1
Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives.乳腺癌中分子靶标和代谢途径的影像学研究：改善临床管理的现状和未来展望。
Int J Mol Sci. 2024 Jan 26;25(3):1575. doi: 10.3390/ijms25031575.
2
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer.正电子发射断层扫描/计算机断层扫描在乳腺癌诊断、分期和治疗中的作用演变。
Mol Imaging Biol. 2019 Feb;21(1):1-10. doi: 10.1007/s11307-018-1181-3.

本文引用的文献

1
The SUVmax for (18)F-FDG correlates with molecular subtype and survival of previously untreated metastatic breast cancer.（18）F-FDG 的 SUVmax 与未经治疗的转移性乳腺癌的分子亚型和生存相关。
Clin Nucl Med. 2013 Apr;38(4):256-62. doi: 10.1097/RLU.0b013e3182816318.
2
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.免疫组化定义的 luminal A 型乳腺癌中孕激素受体阳性肿瘤细胞的预后意义。
J Clin Oncol. 2013 Jan 10;31(2):203-9. doi: 10.1200/JCO.2012.43.4134. Epub 2012 Dec 10.
3
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes.
乳腺癌新辅助化疗后 18F-FDG 肿瘤代谢的变化：肿瘤亚型的影响。
Ann Oncol. 2012 Oct;23(10):2572-2577. doi: 10.1093/annonc/mds071. Epub 2012 Apr 12.
4
Increased FDG uptake in breast cancer is associated with prognostic factors.乳腺癌中氟代脱氧葡萄糖摄取的增加与预后因素相关。
Ann Nucl Med. 2012 May;26(4):345-50. doi: 10.1007/s12149-012-0579-2. Epub 2012 Feb 24.
5
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.采用 21-18F-氟-16α,17α-[(R)-(1'-α-糠叉基)二氧]-19-去甲孕甾-4-烯-3,20-二酮进行乳腺癌孕激素受体的 PET 评估。
J Nucl Med. 2012 Mar;53(3):363-70. doi: 10.2967/jnumed.111.098319. Epub 2012 Feb 13.
6
Practical implications of gene-expression-based assays for breast oncologists.基于基因表达的检测对乳腺肿瘤医生的实际影响。
Nat Rev Clin Oncol. 2011 Dec 6;9(1):48-57. doi: 10.1038/nrclinonc.2011.178.
7
Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.乳腺癌中 18F-FDG 摄取与临床病理及免疫组化预后因素的相关性。
Ann Nucl Med. 2012 Feb;26(2):175-83. doi: 10.1007/s12149-011-0556-1. Epub 2011 Dec 3.
8
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.乳腺癌中 Ki67 的评估：国际乳腺癌 Ki67 工作组的建议。
J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64. doi: 10.1093/jnci/djr393. Epub 2011 Sep 29.
9
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.亚型策略——应对乳腺癌的多样性：2011 年圣加仑国际乳腺癌专家共识会议关于早期乳腺癌初始治疗的要点。
Ann Oncol. 2011 Aug;22(8):1736-47. doi: 10.1093/annonc/mdr304. Epub 2011 Jun 27.
10
Should liver metastases of breast cancer be biopsied to improve treatment choice?乳腺癌肝转移是否需要活检以改善治疗选择？
Ann Oncol. 2011 Oct;22(10):2227-33. doi: 10.1093/annonc/mdq751. Epub 2011 Feb 22.